Skip to main content

Peer Review reports

From: The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients

Original Submission
15 Mar 2016 Submitted Original manuscript
27 Jul 2016 Reviewed Reviewer Report - Oluwaseun Adebayo Bamodu
14 Dec 2016 Author responded Author comments - Kenneth Mark
Resubmission - Version 2
14 Dec 2016 Submitted Manuscript version 2
25 Dec 2016 Reviewed Reviewer Report - Oluwaseun Adebayo Bamodu
17 Jan 2017 Reviewed Reviewer Report - Kumardeep Chaudary
17 Feb 2017 Author responded Author comments - Kenneth Mark
Resubmission - Version 3
17 Feb 2017 Submitted Manuscript version 3
6 Mar 2017 Reviewed Reviewer Report - Kumardeep Chaudary
17 Apr 2017 Author responded Author comments - Kenneth Mark
Resubmission - Version 4
17 Apr 2017 Submitted Manuscript version 4
Publishing
24 Apr 2017 Editorially accepted
2 May 2017 Article published 10.1186/s12885-017-3297-2

You can find further information about peer review here.

Back to article page